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The clinical course associated with dense deposits in the kidney
basement membranes. Thirty-four cases of a special form of
chronic glomerulonephritis characterized by dense deposits in
the basement membranes of the kidney have been statistically
analyzed for their clinical symptoms and evolution. Comparisons
were established with other groups of chronic glomerulonephri-
tides (457) especially membranoproliferative (49) and lobular
(24) forms. The frequency of BMDDD was 1.75% among the
group of chronic glomerulonephritides. An acute onset of the
disease was frequent and consisted mainly of acute glomerulone-
phritis-like episodes, asymptomatic macroscopic hematuria or a
nephrotic syndrome. These initial situations were more common
among the younger patients. During the course of the disease, the
occurrence of a nephrotic syndrome was more frequent than in
other types of chronic glomerulonephritis. A specific clinical
feature may be the occurrence of an episode of transitory renal
insufficiency from which the patient recovers completely. The
mean mortality rate of the disease was very consistent during
the first twelve years (5%/year), this being close to that of the
group of patients with chronic glomerulonephritis. However, the
mortality rate of the lobular forms was significantly higher
(10%/year). The occurrence of the nephrotic syndrome, ami-
crobial leukocyturia or hypergammaglobulinemia were ominous.
The distinctive characteristics of some of the clinical symptoms
reinforce the autonomy of the renal disease corresponding with
basal membrane dense deposits.
Evolution cinique des nephropathies avee dépôts denses dans les
membranes basales. 34 observations de glomérulonéphrite
chronique, auxquelles correspondaient des lesions rénales
caracterisées par des dépôts denses dans toutes les membranes
basales du rein, ont été analysées. Des comparaisons statistiques
ont été établies avec d'autres categories de glomerulonéphrite
chronique (457), particulièrement les glomérulonéphrites mem-
branoprolifératives (49) et lobulaires (24). La fréquence globale
de la maladie de dépôts denses dans les basales est de 1,75% de
l'ensemble des glomérulopathies chroniques. Le debut clinique
est frequemment aigu: episode ressemblant a une gloméruloné-
phrite aiguë, hématurie macroscopique ou syndrome néphrotique.
Ceci est particuliCrement frequent chez les sujets les plus.jeunes.
Plus tard, les syndromes nbphrotiques sont particuliêrement
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frequents. Un trait clinique original est Ia possibilité d'épisodes
d'insuffisance rénale entiérement reversible. Le taux moyen de
mortalité annuelle est constant pendant les 12 premieres années
(5 % par an), cc qui est du méme ordre de grandeur que pour
l'ensemble des glomerulopathies chroniques, mais nettement
meilleur que dans les glomérulonéphrites lobulaires (10% par an).
La survenue d'un syndrome néphrotique, l'existence d'une
leucocyturie amicrobienne et d'une hypergammablobulinCmie
annonce souvent l'insuffisance rénale. L'autonomie de Ia maladie
des dépôts denses dans les basales est done renforcée par un cer-
tain nombre de traits cliniques evolutifs originaux.
A new lesion of the kidney was described in 1963 by
Berger and Galle [1, 2]. Light and electron microscopic
observations showed that its main pathological change
consisted of an abnormally dense substance deposited
within the glomerular and tubular basement membranes.
The specificity of this lesion has been under review for
several years. It was recently reassessed by Galle, Hinglais,
and Crosnier [3], who reported the early recurrence of an
identical lesion in kidneys that were transplanted into three
patients who had exhibited this nephropathy. Until now
the clinical course of this type of renal disease has never
been investigated using statistical analysis. We present here
the results of a clinical study of 34 patients who exhibited
this pathological lesion.
Methods
Kidney biopsy specimens from 34 patients comprise the
main source of the histologic material in this study. In two
patients, histologic data were obtained at autopsy only.
Three patients underwent repeated biopsy.
In addition to the light microscopic examination of all
specimens, 21 biopsies were also submitted to electron
microscopy. Immunofluorescence studies of biopsy speci-
mens from seven patients in the present series have been
previously reported [4], as have other data from immuno-
fluorescence microscopy [5].
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The lesion of basement membrane dense deposit disease
(BMDDD) is characterized by the presence of an abnor-
mally dense substance inside the basement membranes
(BM) of the kidney. All of the basement membranes are
involved including those of the peripheral capillary loops
within the glomerular tuft, Bowman's capsule, and the
renal tubules. In addition, an identically dense material
is present in the intercapillary or mesangial region of the
glomerular tuft (Figs. 1, 2). With electron microscopy, the
abnormal substance appears quite dense and without def i-
nite structure, even at the highest magnifications after
fixation with osmium tetroxide (Fig. 1). With light micro-
scopy the dense substance exhibits many of the same tinc-
tonal features as does "fibrinoid". Histochemical analysis
has shown that the substance contains neutral mucopoly-
saccharides [6]. Immunofluorescence studies demonstrate
that the substance contains no immunoglobulins [4, 5, 7],
unlike the material forming extramembranous, submem-
branous or intercapillary fibrinoid deposits. Even in the
terminal stages of the disease, the specific lesions remain
easily recognizable despite extensive hyalinization of the
glomeruli. The basement membranes of other tissues and
vessels in the body appear unaffected.
Other histological lesions are often associated with these
intramembranous deposits; they include flattening of the
foot processes, proliferation of the intercapillary cells
(often with increased basement membrane-like substance
around the cells), and less frequently, proliferation of the
cells of Bowman's capsule (Fig. 2). In two patients, how-
ever, the membranous deposits were an isolated finding,
a situation similar to that observed when the lesions were
found to have recurred in transplanted kidneys [3].
Clinical studies were performed on 34 patients that were
selected on the basis of the pathological criteria stated
above. These studies were conducted in specialized wards
where standardized laboratory techniques were employed.
Patients were followed for varying periods of time; five
were followed for less than one year, thirteen from one to
five years, six from five to ten years, and ten for more than
ten years. Mortality rates were computed according to the
Fig. 1. Electron micrograpli of basement membrane dense deposits. Deposits are localized in the middle layer of the basement mem-
brane (lamina densa). They are extremely electron-dense. Dense deposits are also present within the intercapillary space or
mesangium (uranyl acetate and lead stain; original magnification x 40,000) (courtesy of Dr. P. Galle).
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Fig. 2. Light micrograph depicting the typical appearance of glomeruli th BMDDD. The glomerular capillary walls are irregularly
infiltrated with long dark ribbon-like deposits of a very chromophilic substance (Trichrome light green; original magnification x 400)
(courtesy of Dr. N. Hinglais).
classical formula [81:
M D
L— —--
where M =mortality rate, D =number of patients dying
during a defined interval, L =number of patients living at
the beginning of the defined interval, and LE =number of
patients excluded but living during a defined interval.
A sample of 457 patients with various forms of chronic
glomerulonephritis was collected according to the same
general criteria as above and served as a statistical control.
The control data were computed by electronic processes [9].
Histological classification of this group was that used by
Hamburger et al [101. Statistical comparisons were made
between data derived from the 34 patients with the base-
ment membrane dense deposit disease and that from the
group of 457 patients with chronic glomerulonephritides,
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including 49 patients with membranoproliferative disease
and 24 patients with lobular glomerulonephritides (Hin-
glais, N., and de Montera, H.: Unpublished observations).
Results
Of the 457 patients forming the group of chronic glomer-
ular nephritides, 1.75 % had basement membrane dense
deposits as the characteristic pathological feature. In this
group of 34 patients with dense deposit disease of the base-
ment membranes, 22 were males and 12 were females, a sex
difference which is statistically significant (P <0.01). The
median age was 16 when the first symptom appeared
(80% of the patients were less than 25 years of age).
Among the 34 patients with dense deposit disease of the
basement membranes, eight patients (23%) had no antece-
dent medical history suggestive of renal disease. Of the
remaining patients, 71 % had a history of some type of
antecedent infectious disease; 59% were in the upper
respiratory tract, 15 % in the urinary tract, and 9% had
scarlet fever. All episodes of infection preceded the first
symptom of renal disease by more than two months. Among
the few with a non-infectious history were two patients
with familial juvenile gout.
In 38% of the 34 patients the initial picture was similar
to that of an acute glomerulonephritis; the first symptoms
consisted of edema, proteinuria, hematuria, oliguria and
renal insufficiency. Anti-streptolysin-O titers were not
measured. Serum complement levels were normal in the
five instances in which they were measured. In two patients
(6%), the onset of the disease was marked by an episode
of acute anuria suggesting the diagnosis of malignant
glomerulonephritis. In 30% of the patients, the initial
symptom was macroscopic hematuria, sometimes asymp-
tomatic (8%). In 12% of the patients the initial course
was that of a progressive nephrotic syndrome. Fifteen per-
cent of the patients presented initially with asymptomatic
persistent proteinuria [11], or a proteinuria associated with
microscopic hematuria (15%). In only two patients did
the disease present as chronic renal insufficiency without
other symptoms. Comparison of the characteristic symp-
toms with the age of the patients indicated that a "flaring"
onset (macroscopic hematuria, anuria, acute glomerulone-
phritis-like episode or nephrotic syndrome) was more
common among patients less than 17 years of age (78%)
than among the older patients (31 %), but this was not
statistically significant (P <0.2).
A nephrotic syndrome occurred 25 times among 22
patients (65%). Two of these 22 patients suffered one or
two relapses after several years of remission. These nephro-
tic episodes occurred at various times after the clinical
onset of the disease; on four occasions the patient presented
with the nephrotic syndrome initially, three times the
nephrotic syndrome occurred during the first year, nine
times it occurred between the second and the fifth years,
and nine times it first appeared after five years of illness.
The nephrotic syndrome occurred as long as 16 years after
the clinical onset of the disease. The duration of the nephro-
tic syndrome varied from several months to several years
(maximum five years) and it was followed by persistent and
moderate proteinuria 35% of the time, or by progressive
renal insufficiency in 65 % of the patients. The course of
the nephrotic syndrome in these patients was seemingly
not influenced by corticoid, immunosuppressive, anti-
malarial or anti-inflammatory therapy. With the exception
of one patient, the nephrotic syndrome was most often
(84%) of moderate intensity and associated with micro-
scopic hematuria. There was no correlation between the
age of the patient and the frequency and evolution of a
nephrotic episode (age at onset ranged between 11 and 52
years).
Acute glomerulonephritis-Iike episodes always occurred
as the presenting clinical sign of the disease, with the ex-
ception of one patient in whom a relapse occurred four
years after the first episode. The duration of renal insuffi-
ciency, edema, gross hematuria and arterial hypertension
was abnormally long in comparison with a typical case of
acute glomerulonephritis. The total time of recovery from
symptoms, except for proteinuria and microscopic hema-
tuna, usually ranged between two and twelve months.
In 21 % of the patients, the recovery of renal function was
incomplete and death occurred in one patient four months
after the acute onset of the glomerulonephritis-like epi-
sode. A nephrotic syndrome was not observed in the after-
math of the glomerulonephritis-like episodes.
Proteinuria was observed in all patients. In two patients
(6%) the proteinuria was stable and asymptomatic with no
other detectable manifestations of renal disease for a
period of time as long as eight years (one case). In two
other patients the asymptomatic proteinuria was transient,
changing after a few months into a nephrotic syndrome or
a new episode with hematuria. In two additional patients
the proteinuria became purely orthostatic and has remained
so for three years.
Macroscopic heinaturia was observed in 14 patients (41 %)
either as an isolated symptom or as a part of an acute gb-
merulonephritis-like episode. Macroscopic hematuria was
often one of the initial symptoms.
Arterial hypertension was present during the course of
21 observations (62%). In some of the patients (19%)
hypertension was a transient symptom associated with the
acute onset of the disease or terminal renal insufficiency,
but it rarely occurred in association with a nephrotic
episode. Hypertension was generally moderate in severity
except when associated with renal insufficiency late in the
illness. Changes in the ocular I undi were never observed in
the absence of hypertension.
Reversible episodes of renal insufficiency were observed
nine times in eight patients (24%). Most often these epi-
sodes occurred during the clinical onset of the disease, but
in three cases acute renal insufficiency was observed during
the course of the disease at the second, fifth and eight
Number of living patientu at beginning of each intervalu
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years. One of the patients exhibited two reversible episodes
separated by a four year remission during which time renal
function was normal. These episodes appeared as subacute
renal insufficiency in which the BUN rose progressively
to 50 to 150 mg/100 ml, and they lasted from one to six
months. Return of renal function was excellent in eight of
nine episodes. The eventual prognosis was not dependent
on such reversible renal manifestations (two patients have
been observed with normal function ten years after an
episode of reversible renal insufficiency).
Less frequent clinical manifestations included fever in six
cases (18 %). Fever was sometimes associated with arthral-
gias at the clinical onset, lasting from several days to several
weeks. A skin rash was also reported at the onset on three
occasions.
Amicrobial leukocyturia was often observed (47%). In
12 observations, urinary leukocyte excretion was between
10 and lo5fmin with a similar value for urinary erythro-
cyte excretion. In four cases leukocyturia occurred without
significant microscopic hematuria, and this has been ob-
served for several years.
Microscopic hematuria was a frequent sign, but in 29 %
of the observations there were transient periods of time
when hematuria was absent (even in a patient with renal
insufficiency).
The plasma proteins were often abnormal. In the nephro-
tic syndrome associated with a low serum albumin, the
oc2-globulin was abnormally high in nearly every instance.
The y-globulin fraction often appeared elevated (up to
36%), but the absolute y-globulin titer (g/liter) was normal
in all but two instances. Even in the presence of the nephro-
tic syndrome, the absolute level of y-globulin was normal
or high in 86% of the cases, in contrast to the hypogamma-
globulinemia which is so commonly encountered in other
forms of the nephrotic syndrome.
In the urine, albumin represented 50 to 90% of the total
urine protein excretion when studied by paper electro-
phoresis. The y- and fl-globulins represented less than 15%
of the total. The whole electrophoretic pattern was "selec-
tive" as long as renal function was not severely impaired.
General evolution. The general course of the disease was
variable in each individual patient. One group of seven
patients appeared to have a stable disease and they exhi-
bited no evidence of renal insufficiency during periods of
observation as long as 22 years. A second group of 15
patients exhibited progressive renal insufficiency beginning
at various times after the initial onset of symptoms (from
onset to eight years). Renal function deteriorated rapidly
and the kidney was often destroyed after only one year of
evolution. The clinical course of a third group of eleven
patients was characterized by episodes of reversible renal
insufficiency. An episode of renal insufficiency often occur-
red at the onset of the disease, and it was followed by
complete recovery within a few months and a stable clinical
course thereafter.
Table 1. Annual mortality and survival rates in basement
membrane dense deposit disease
Intervals Mortality rate Survival rate
During Corrected During Corrected
the per annum the per annum
defined defined
period period
of time of time
1 to 6 mos 0.030 0.060 0.970 0.940
7 mos to 1 yr 0.031 0.062 0.969 0.938
2nd yr 0.032 0.032 0.968 0.968
3 and 4 yrs 0.085 0.042 0.915 0.958
5 and 6 yrs 0.100 0.050 0.900 0.950
7 and 8 yrs 0.133 0.066 0.867 0.934
9 and 10 yrs 0.095 0.047 0.905 0.963
11 to 15 yrs 0.266 0.053 0.734 0.947
16 to 20 yrs 0.250 0.050 0.750 0.950
Prognosis. The mean annual mortality rate was 5%
(Table 1). It was remarkably constant from the time of
onset through the 20th year of the disease with insignificant
differences from one year to another. That is to say, the
probability of survival for any one patient was the same
within any defined period of time, regardless of the duration
of the disease (Fig. 3). The 50% statistical mortality occur-
red between the 11th and 12th years after the onset of initial
symptoms.
Fig. 3. Histogram of the cumulative survival rate from the onset
ofBMDDD to the 20th year of evolution. The slope is remarkably
constant. The 50% mortality rate is around the 12th year after
the initial symptom.
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Neither progressive renal insufficiency nor the mortality
rate correlated with a previous occurrence of transient renal
insufficiency (either at the onset or during the course of the
disease). The same was true for episodes of pseudo-acute
glomerulonephritis or of macroscopic hematuria. On the
other hand, the mortality rate was higher for patients
presenting with an abnormal excretion rate of urinary
leukocytes in the absence of bacteriuria (annual mortality
=0.069) than for patients without abacterial leukocyturia
(annual mortality = 0.004); the difference was statistically
significant (P <0.02). Also, the occurrence of the nephro-
tic syndrome was ominous as the annual mortality rate
rose to 0.15 during the succeeding year. However this was
not the case if the nephrotic syndrome was not followed
rapidly by renal failure (annual mortality =0.045).
The very few patients with a high plasma level of y-
globulins exhibited a severe clinical course. Conversely,
none of the four cases with a low plasma level of y-globulins
showed a poor prognosis, but this was not statistically
significant.
Pathological findings and their correlations. Endocapil-
lary cell proliferation was absent in only four kidneys, two
of which had obsolete glomeruli and two of which had
minor lesions. These last two patients differed in their
clinical evolution, one exhibited a very stable clinical course
and one demonstrated progressive renal insufficiency. Of
the remaining patients, the kidneys of 16 presented with
moderate endocapillary cell proliferation and the kidneys
of 12 had significant proliferation. There was no correlation.
between the degree of endocapillary cell proliferation and
symptoms at the time of renal biopsy or late prognosis.
The presence of hyaline substance in the glomeruli, even in
large quantities,. was not correlated with the overall evo-
lution of the disease, since the patients surviving for the
longest time without renal insufficiency could present with
intense hyaline deposits in their kidneys. There was a signifi-
cant correlation between extracapillary proliferation, ob-
served in the kidneys of 12 patients, and recent acute
glomerulonephritis-like episodes, a recent nephrotic syn-
drome (P <0.01), or renal insufficiency (P <0.03), but not
with late evolution. Vascular lesions observed in the renal
biopsy were not correlated with either symptoms or clinical
course.
Discussion
The specificity of the histological lesions of basement
membrane dense deposit disease (BMDDD) has been
reassessed recently because of the early recurrence of identi-
cal lesions in kidneys transplanted into patients who origi-
nally exhibited this form of renal disease [3]. One must
Table 2. Frequency of signs and symptoms a
Chronic
glomerulo-
nephritides
membrano-
proliferative
glomerulo-
nephritis
Lobular
glomerulo-
nephritides
Basement
membrane
dense deposit
disease
No. of patients 467 49 24 34
Sex ratio (M/F) (58/42) (48/52) (62/38) (64/36)
Median age at clinical onset 16 yrs 16 yrs 16 yrs 16 yrs
Initial symptoms
Acute glomerulonephritis-like
episode
9%
(40/416)
2%
(1/48)
5%
(1/23)
38%
(13/21)
Gross hematuria 18%
(80/368)
10%
(5/44)
17%
(4/20)
30%
(10/24)
Nephrotic syndrome 35%
(160/296)
20%
(10/39)
64%
(14/8)
12%
(4/30)
Protejnuria with or without micro-
scopic hematuria
46%
(207/249)
69%
(34/15)
32%
(7/15)
30%
(10/24)
Symptoms during course of the disease
Nephrotic syndrome 40%
(182/274)
49%
(24/25)
66%
(16/8)
65%
(22/12)
Gross hematuria 21%
(96/360)
19%
(9/40)
33%
(8/16)
41%
(14/20)
.Amicrobial leucocyturia 0't' to
(200/256)
0/
-t io
(21/28)
O/0
(8/16)
A7O/o
(16/18)
Relative hypergammaglobulinemia
(above 20%)
43%
(196/260)
45%
(22/27)
45%
(11/13)
40%
(11/17)
a Numbers within parentheses indicate the number of patients with and without the symptom.
426 Antoine /Faye
question the specificity of the clinical features that are
associated with these lesions. Statistical comparisons may
provide a significant answer to this question [121.
The sex ratio of BMDDD was characterized by a male
predominance that was significantly higher than that ob-
served in other forms of chronic glomerulonephritis. How-
ever, the mean age at the time of onset and the median
age (16 years) did not differ significantly in any of the
groups studied.
Several of the initial symptoms were statistically peculiar
to this disease (Table 2). Acute glomerulonphritis-like
episodes were more frequent at the onset of BMDDD
(38%) than at the onset of disease in the 457 patients with
chronic glomerulonephritides (9%), or in patients with
membranoproliferative glomerulonephritides (2%) or in
patients with lobular glomerulonephritides (5%); these
differences were highly significant (P <0.001). The high
incidence of gross hematuria (30%) was not statistically
significant in the group of patients with BMDDD except
when compared with patients having membranoprolifera-
tive glomerulonephritides where gross hematuria was a
rare finding (10%) (P<0.05). Conversely, the nephrotic
syndrome occurred less frequently at the onset of the
BMDDD (12%) than at the onset of the chronic glomerulo-
nephritides (35%) (P<0.01), or at the onset of the lobular
glomerulonephritides (64%) (P <0.001).
The general frequency of the symptoms that were observed
during the course of the disease (Table 2) was different only
insofar as the nephrotic syndrome was concerned. It
occurred more frequently (65%) during the course of
BMDDD that it did in patients with the chronic glomerulo-
nephritides (40%) (P <0.02); however, the difference was
minimal in comparison with lobular glomerulonephritis
(66%).
When one compares the mortality rate in BMDDD with
other chronic glomerulonephnitides no significant difference
appears except for the lobular form (Fig. 4). After a nine
year course, the cumulative survival rates were 64.9% for
BMDDD, 67.9% for the chronic glomerulonephritides and
55.9% for membrano-proliferative glomerulonephritides
but only 35.9% for the lobular form (P <0.001). One-half
of the patients were still surviving by the 12th year of
evolution in BMDDD, by the 13th year for chronic glomer-
ulonephritides and by the 11th year for the membranopro-
liferative forms. Only one-half of the patients with lobular
forms survived to the seventh year.
The statistical comparison of the prognostic value of
some symptoms reveals that hypergammaglobulinemia
(above 20%) is as ominous in all forms of chronic glomer-
ulonephritides as in the BMDDD. The occurrence of a
nephrotic syndrome and the presence of amicrobial
leukocyturia are not correlated with a worsened prognosis
in all forms of chronic glomerulonephrjtjdes, whereas they
are in BMDDD.
Finally, BMDDD resembles other chronic glomerulo-
nephritides in many features; however, a few signs give it
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Fig. 4. Comparative histograms of the cumulative survival rates
for 457 patients with chronic glomerulonephritides (CGN), 49
patients with membranoproliferative glomerulonephritis (M— F)
and 24 patients with lobular glomerulonephritis (LGN). For each
group, the slope is comparatively regular from the onset of the
disease throughout the first decade.
a rather distinctive course, such as the frequent acute onset,
the episodes of transitory renal insufficiency, and the omi-
nous influence of the nephrotic syndrome and amicrobial
leukocyturia. The steadiness of the mortality rate through-
out the first decade of evolution was another interesting
feature, not specific, but especially striking in the BMDDD.
This type of statistical approach to the natural history of
a chronic disease of the kidney may be a new way of in-
vestigating renal pathology.
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